{"id":528,"date":"2026-03-12T17:26:13","date_gmt":"2026-03-12T16:26:13","guid":{"rendered":"https:\/\/biotechlerncenter.iph-multisite.berta-bewegt.ch\/?page_id=528"},"modified":"2026-03-13T17:53:48","modified_gmt":"2026-03-13T16:53:48","slug":"4-aspects-ethiques-les-prix-des-medicaments-pretent-a-la-discussion","status":"publish","type":"page","link":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/production-de-medicaments\/4-aspects-ethiques-les-prix-des-medicaments-pretent-a-la-discussion\/","title":{"rendered":"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion"},"content":{"rendered":"\n<p>Peut-on mettre en balance le prix d&rsquo;un m\u00e9dicament et la sant\u00e9 d&rsquo;un patient ? Les nouveaux m\u00e9dicaments, plus efficaces et mieux tol\u00e9r\u00e9s &#8211; qui sont souvent plus chers &#8211; ne doivent-ils \u00eatre accessibles qu&rsquo;aux patients b\u00e9n\u00e9ficiant d&rsquo;une meilleure situation financi\u00e8re ? Doit-on refuser un m\u00e9dicament extr\u00eamement cher \u00e0 une personne \u00e2g\u00e9e ?<\/p>\n\n\n\n<p>Les prix des m\u00e9dicaments suscitent de plus en plus de discussions dans le cadre du d\u00e9bat sur les co\u00fbts du syst\u00e8me de sant\u00e9. Les organisations de consommateurs et les caisses d&rsquo;assurance-maladie consid\u00e8rent les prix de nombreux m\u00e9dicaments comme excessivement \u00e9lev\u00e9s en Suisse par rapport \u00e0 l&rsquo;\u00e9tranger et exigent une baisse des prix. S&rsquo;agissant des nouveaux m\u00e9dicaments, les prix pratiqu\u00e9s en Suisse ne sont toutefois pas sup\u00e9rieurs en r\u00e8gle g\u00e9n\u00e9rale \u00e0 ceux pratiqu\u00e9s dans des pays europ\u00e9ens comparables ; ils sont souvent plus faibles qu&rsquo;en Allemagne ou en Grande-Bretagne et le plus souvent nettement plus \u00e9lev\u00e9s qu&rsquo;aux Etats-Unis. Il importe en outre de consid\u00e9rer que, pour les m\u00e9dicaments rembours\u00e9s par les caisses, les prix ne se forment pas sur le march\u00e9 libre, mais sont r\u00e9gul\u00e9s par l&rsquo;Etat.<\/p>\n\n\n\n<p>En particulier, les nouveaux m\u00e9dicaments &#8211; plus efficaces et g\u00e9n\u00e9ralement mieux tol\u00e9r\u00e9s -, aboutissent \u00e0 ce que les d\u00e9penses engag\u00e9es pour les m\u00e9dicaments augmentent chaque ann\u00e9e. Dans le m\u00eame temps, ces nouveaux m\u00e9dicaments et ces nouveaux traitements am\u00e9liorent la qualit\u00e9 de vie des patientes et des patients, et augmentent leurs chances de gu\u00e9rison et de survie. Ainsi, au d\u00e9but du 20e si\u00e8cle, rares \u00e9taient les malades qui parvenaient \u00e0 vaincre un cancer. Aujourd&rsquo;hui, six canc\u00e9reux sur dix sont encore en vie cinq ans apr\u00e8s la pose du premier diagnostic.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg\" alt=\"\" class=\"wp-image-4269\"\/><figcaption>\u00a9 Barbara Jung<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Peut-on mettre en balance le prix d&rsquo;un m\u00e9dicament et la sant\u00e9 d&rsquo;un patient ? Les nouveaux m\u00e9dicaments, plus efficaces et mieux tol\u00e9r\u00e9s &#8211; qui sont souvent plus chers &#8211; ne doivent-ils \u00eatre accessibles qu&rsquo;aux patients b\u00e9n\u00e9ficiant d&rsquo;une meilleure situation financi\u00e8re ? Doit-on refuser un m\u00e9dicament extr\u00eamement cher \u00e0 une personne \u00e2g\u00e9e ? Les prix des [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":850,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"page-templates\/unterthema.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-528","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion - biotechlerncenter<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion\" \/>\n<meta property=\"og:description\" content=\"Peut-on mettre en balance le prix d&rsquo;un m\u00e9dicament et la sant\u00e9 d&rsquo;un patient ? Les nouveaux m\u00e9dicaments, plus efficaces et mieux tol\u00e9r\u00e9s &#8211; qui sont souvent plus chers &#8211; ne doivent-ils \u00eatre accessibles qu&rsquo;aux patients b\u00e9n\u00e9ficiant d&rsquo;une meilleure situation financi\u00e8re ? Doit-on refuser un m\u00e9dicament extr\u00eamement cher \u00e0 une personne \u00e2g\u00e9e ? Les prix des [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/\" \/>\n<meta property=\"og:site_name\" content=\"biotechlerncenter\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-13T16:53:48+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/\",\"name\":\"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion - biotechlerncenter\",\"isPartOf\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg\",\"datePublished\":\"2026-03-12T16:26:13+00:00\",\"dateModified\":\"2026-03-13T16:53:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#primaryimage\",\"url\":\"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg\",\"contentUrl\":\"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sujets\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Production de m\u00e9dicaments\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/production-de-medicaments\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/#website\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/\",\"name\":\"biotechlerncenter\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/biotechlerncenter.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion - biotechlerncenter","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/","og_locale":"fr_FR","og_type":"article","og_title":"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion","og_description":"Peut-on mettre en balance le prix d&rsquo;un m\u00e9dicament et la sant\u00e9 d&rsquo;un patient ? Les nouveaux m\u00e9dicaments, plus efficaces et mieux tol\u00e9r\u00e9s &#8211; qui sont souvent plus chers &#8211; ne doivent-ils \u00eatre accessibles qu&rsquo;aux patients b\u00e9n\u00e9ficiant d&rsquo;une meilleure situation financi\u00e8re ? Doit-on refuser un m\u00e9dicament extr\u00eamement cher \u00e0 une personne \u00e2g\u00e9e ? Les prix des [&hellip;]","og_url":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/","og_site_name":"biotechlerncenter","article_modified_time":"2026-03-13T16:53:48+00:00","og_image":[{"url":"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/","url":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/","name":"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion - biotechlerncenter","isPartOf":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#primaryimage"},"image":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#primaryimage"},"thumbnailUrl":"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg","datePublished":"2026-03-12T16:26:13+00:00","dateModified":"2026-03-13T16:53:48+00:00","breadcrumb":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#primaryimage","url":"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg","contentUrl":"http:\/\/biotechlerncenter.interpharma.ch\/wp-content\/uploads\/sites\/4\/2020\/02\/dsc1374.bbarbara_jung_72.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/herstellung-von-medikamenten\/4-ethische-aspekte-medikamentenpreise-geben-zu-reden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Sujets","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/"},{"@type":"ListItem","position":3,"name":"Production de m\u00e9dicaments","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/production-de-medicaments\/"},{"@type":"ListItem","position":4,"name":"4. Aspects \u00e9thiques: les prix des m\u00e9dicaments pr\u00eatent \u00e0 la discussion"}]},{"@type":"WebSite","@id":"https:\/\/biotechlerncenter.interpharma.ch\/#website","url":"https:\/\/biotechlerncenter.interpharma.ch\/","name":"biotechlerncenter","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biotechlerncenter.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=528"}],"version-history":[{"count":3,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/528\/revisions"}],"predecessor-version":[{"id":3195,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/528\/revisions\/3195"}],"up":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/850"}],"wp:attachment":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}